Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
Walraven, Maudy, Homs, Marjolein Y. V., van der Veldt, Astrid A. M., Dekker, Henk, Koldenhof, Jose, Honeywell, Richard, Barendrecht, Arjan, Sebastian, Silvie A. E., Parr, Naomi, Koekman, Arnold C., VoLanguage:
english
Journal:
Angiogenesis
DOI:
10.1007/s10456-018-9598-5
Date:
March, 2018
File:
PDF, 1.16 MB
english, 2018